ADIL

Adial Pharmaceuticals, Inc

0.24

USD

ADIL Earnings Reports

Positive Surprise Ratio

ADIL beat 13 of 25 last estimates.

52%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.08

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-77.14%

Adial Pharmaceuticals, Inc earnings per share and revenue

On Nov 13, 2025, ADIL reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 43.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.91% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Adial Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Adial Pharmaceuticals, Inc reported EPS of -$0.08, beating estimates by 43.98%, and revenue of $0.00, 0% as expectations.

How did the market react to Adial Pharmaceuticals, Inc's Q3 2025 earnings?

The stock price moved up 1.91%, changed from $0.32 before the earnings release to $0.33 the day after.

When is Adial Pharmaceuticals, Inc expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Adial Pharmaceuticals, Inc's next earnings report?

Based on 5 analysts, Adial Pharmaceuticals, Inc is expected to report EPS of -$0.08 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.